Kirsten H. Limesand earned her BS in Microbiology from North Dakota State University and her PhD in Microbiology with an emphasis in virology from Colorado State University. She then completed post-doctoral training at the University of Colorado Health Sciences Center where she first began her work on the regulation of apoptosis in salivary glands exposed to different damaging agents. In 2005, she was hired as an Assistant Professor at the University of Arizona. She was promoted to Associate Professor in 2011 and Full Professor in 2015.
Please contact Melynda Noble for Zoom Info
- Describe the inflammatory phase phenotypes following radiotherapy
- Explain the proliferative phase phenotypes following radiotherapy
- Discuss the impact of inflammation and proliferation on re-differentiation phenotypes following radiotherapy
The University of Arizona College of Medicine ‐ Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine ‐ Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.